BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)

SHA:688166 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	20,924	20,740	12,748	14,786	9,535	15,051
Market Cap Growth	41.88%	62.70%	-13.79%	55.07%	-36.65%	-19.85%
Enterprise Value	22,683	22,558	14,391	15,983	10,606	15,560
Last Close Price	49.52	49.06	30.15	34.85	22.36	36.17
PE Ratio	383.83	369.98	67.39	73.03	39.79	61.70
Forward PE	-	28.00	28.00	28.00	28.00	43.06
PS Ratio	17.10	16.95	9.94	12.54	9.37	14.30
PB Ratio	7.35	8.19	5.23	6.12	4.25	8.64
P/TBV Ratio	8.57	8.79	5.54	6.52	4.54	9.47
P/OCF Ratio	64.34	-	51.91	75.92	30.63	85.48
EV/Sales Ratio	18.54	18.43	11.22	13.55	10.43	14.79
EV/EBITDA Ratio	108.31	201.40	48.52	58.11	39.13	54.92
EV/EBIT Ratio	-	1393.20	71.68	76.75	45.84	62.45
Debt / Equity Ratio	0.93	0.93	0.92	0.91	0.90	0.52
Debt / EBITDA Ratio	20.90	20.90	7.20	7.71	7.17	3.10
Net Debt / Equity Ratio	0.69	0.69	0.60	0.48	0.35	0.32
Net Debt / EBITDA Ratio	15.49	15.49	4.96	4.21	2.92	1.99
Net Debt / FCF Ratio	-	-	-126.33	-5.54	-1.90	-0.77
Asset Turnover	-	-	0.25	0.24	0.27	0.44
Inventory Turnover	-	-	1.58	1.74	1.63	2.33
Quick Ratio	-	-	1.06	1.49	1.92	1.23
Current Ratio	-	-	1.56	2.00	2.39	1.70
Return on Equity (ROE)	2.26%	2.26%	5.82%	7.44%	10.62%	14.97%
Return on Assets (ROA)	-	-	2.46%	2.69%	3.79%	6.49%
Return on Invested Capital (ROIC)	0.38%	0.40%	4.82%	5.79%	7.57%	13.37%
Return on Capital Employed (ROCE)	-	-	4.90%	5.10%	6.00%	10.40%
Earnings Yield	0.26%	0.27%	1.48%	1.37%	2.51%	1.62%
FCF Yield	-0.61%	-	-0.09%	-1.41%	-4.36%	-4.87%
Dividend Yield	0.03%	-	0.32%	0.27%	0.51%	0.33%
Payout Ratio	215.73%	-	71.75%	56.80%	41.77%	22.26%
Buyback Yield / Dilution	-2.58%	-2.58%	0.34%	-2.10%	-1.61%	1.87%
Total Shareholder Return	-2.38%	-2.58%	0.66%	-1.82%	-1.10%	2.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.